Cargando…

Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases

Interstitial lung diseases (ILDs) are some of the first and most serious complications of connective tissue diseases (CTDs). However, the pathogenesis of CTD-related ILDs (CTD-ILDs) is still unclear and their treatment often depends on functional and radiographic disease progression as well as on pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nucera, Valeria, Gerratana, Elisabetta, Giallanza, Manuela, La Corte, Laura, Sangari, Donatella, Atzeni, Fabiola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioExcel Publishing Ltd 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813436/ https://www.ncbi.nlm.nih.gov/pubmed/33505481 http://dx.doi.org/10.7573/dic.2020-9-1

Ejemplares similares

The Rheumatology Drugs for COVID-19 Management: Which and When?
por: Atzeni, Fabiola, et al.
Publicado: (2021)

Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications
por: Erre, Gian Luca, et al.
Publicado: (2021)

Metabolic Syndrome and Its Components Have a Different Presentation and Impact as Cardiovascular Risk Factors in Psoriatic and Rheumatoid Arthritis
por: Atzeni, Fabiola, et al.
Publicado: (2023)

Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
por: Wang, Pengfei, et al.
Publicado: (2023)

Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial
por: Saunders, Peter, et al.
Publicado: (2017)

Efficacy and safety of Chinese herbal medicines combined with cyclophosphamide for connective tissue disease-associated interstitial lung disease: A meta-analysis of randomized controlled trials
por: Yin, Xietian, et al.
Publicado: (2023)

Evolution of Rheumatoid-Arthritis-Associated Interstitial Lung Disease in Patients Treated with JAK Inhibitors: A Retrospective Exploratory Study
por: Venerito, Vincenzo, et al.
Publicado: (2023)

Psoriatic Arthritis and Metabolic Syndrome: Is There a Role for Disease Modifying Anti-Rheumatic Drugs?
por: Atzeni, Fabiola, et al.
Publicado: (2021)

The Microbiome in Connective Tissue Diseases and Vasculitides: An Updated Narrative Review
por: Talotta, Rossella, et al.
Publicado: (2017)

Interstitial lung disease in suggestive forms of connective tissue disease
por: Fischer, Aryeh
Publicado: (2013)

Pneumothorax in connective tissue disease-associated interstitial lung disease
por: Nishimoto, Koji, et al.
Publicado: (2020)

Management of Connective Tissue Disease–related Interstitial Lung Disease
por: Ahmed, Sakir, et al.
Publicado: (2022)

Nailfold capillaroscopy by smartphone-dermatoscope for connective tissue disease diagnosis in interstitial lung disease: a prospective observational study
por: Jee, Adelle S., et al.
Publicado: (2021)

Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study
por: Cassone, Giulia, et al.
Publicado: (2020)

Cardiovascular Involvement in Connective Tissue Disease: The Role of Interstitial Lung Disease
por: Wang, XiaoBing, et al.
Publicado: (2015)

Detection and Management of Interstitial Lung Diseases Associated With Connective Tissue Diseases
por: Castelino, Flavia V., et al.
Publicado: (2021)

Diagnosis and Management of Interstitial Lung Disease in Patients with Connective Tissue Diseases
por: Koslow, Matthew, et al.
Publicado: (2021)

Interstitial Lung Disease in Mixed Connective Tissue Disease: An Advanced Search
por: Santacruz, Juan Camilo, et al.
Publicado: (2023)

Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease
por: Vacchi, Caterina, et al.
Publicado: (2021)

Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF)
por: Jee, Adelle S., et al.
Publicado: (2017)

Undifferentiated connective tissue disease presenting with prevalent interstitial lung disease: Case report and review of literature
por: Lunardi, Francesca, et al.
Publicado: (2011)

Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management
por: Castelino, Flavia V, et al.
Publicado: (2010)

The Role of Lung Colonization in Connective Tissue Disease-Associated Interstitial Lung Disease
por: Ricci, Alberto, et al.
Publicado: (2021)

Cyclophosphamide for the treatment of Acute Exacerbation of Interstitial Lung Disease: A Review of the Literature
por: Innabi, Ayoub, et al.
Publicado: (2021)

Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 5. Connective Tissue Disease Associated Interstitial Lung Disease
por: Koo, So-My, et al.
Publicado: (2019)

Diagnostic Value of Connective Tissue Disease Related CT Signs in Usual Interstitial Pneumonia Pattern of Interstitial Lung Disease
por: Augustine, Antony, et al.
Publicado: (2022)

Undifferentiated Connective Tissue Disease-Associated Interstitial Lung Disease: Changes in Lung Function
por: Kinder, Brent W., et al.
Publicado: (2010)

Interpretation of autoantibody positivity in interstitial lung disease and lung-dominant connective tissue disease
por: Pereira, Daniel Antunes Silva, et al.
Publicado: (2013)

Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist’s point of view
por: Koo, So-My, et al.
Publicado: (2017)

Exacerbation of connective tissue disease-associated interstitial lung disease due to influenza vaccination
por: Okusaki, Tai, et al.
Publicado: (2021)

Proteomics: Potential techniques for discovering the pathogenesis of connective tissue diseases-interstitial lung disease
por: Wu, Yinlan, et al.
Publicado: (2023)

Expert Opinion Guidance on the Detection of Early Connective Tissue Diseases in Interstitial Lung Disease
por: Namas, Rajaie, et al.
Publicado: (2023)

Diagnosis and Management of Patients with Connective Tissue Disease-related Fibrosing Interstitial Lung Diseases
por: Wang, Bonnie, et al.
Publicado: (2023)

Rituximab for the treatment of acute exacerbation of interstitial lung disease associated with connective tissue disease
por: León Román, Francisco, et al.
Publicado: (2023)

Factors for progressive pulmonary fibrosis in connective tissue disease-related interstitial lung disease
por: Kim, Kyuhwan, et al.
Publicado: (2023)

Comparison of Characteristics of Connective Tissue Disease-Associated Interstitial Lung Diseases, Undifferentiated Connective Tissue Disease-Associated Interstitial Lung Diseases, and Idiopathic Pulmonary Fibrosis in Chinese Han Population: A Retrospective Study
por: Pan, Lin, et al.
Publicado: (2013)

Treatment of Vasodilator-resistant Mixed Connective Tissue Disease-associated Pulmonary Arterial Hypertension with Glucocorticoid and Cyclophosphamide
por: Sugawara, Eri, et al.
Publicado: (2017)

Successful treatment of type B insulin resistance with mixed connective tissue disease by pulse glucocorticoids and cyclophosphamide
por: Yang, Hongbo, et al.
Publicado: (2017)

Proposed method of histological separation between connective tissue disease-associated interstitial pneumonia and idiopathic interstitial pneumonias
por: Ozasa, Mutsumi, et al.
Publicado: (2018)

The Role of the Microbiome in Connective-Tissue-Associated Interstitial Lung Disease and Pulmonary Vasculitis
por: Drakopanagiotakis, Fotios, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ejk1q9s2av28t3ndrcj9nf8b8i